What You Should Know:
– Perimeter Medical Imaging AI, Inc., a medical technology company, is set to advance the capabilities of its surgical imaging solutions with the establishment of the OCT-Tissue Surveillance Registry.
– The database will compile thousands of images and crucial data points from surgeries where Perimeter’s technology is employed.
Enhancing Real-Time Surgical Decision-Making
The value of Perimeter’s Optical Coherence Tomography (OCT) technology in a clinical setting was highlighted by Dr. Jennifer Tittensor, a general surgeon at Timpanogos Regional Hospital and the first contributor to the new registry. “I have used Perimeter’s OCT technology in more than 120 surgeries, and it has become an invaluable tool,” said Dr. Tittensor. “In my practice, it helps me assess margins in real-time and decide whether I need to remove more tissue – potentially avoiding the need for a second surgery. Being a part of the registry allows me to track and analyze patient outcomes and help shape future improvements in the technology. I am excited to be involved.”
Perimeter’s current S-Series OCT leverages the company’s patented wide-field OCT technology, enabling surgeons to visualize tissue specimens in real-time with ultra-high resolution during surgical procedures. Building upon this, the investigational next-generation B-Series OCT with ImgAssist AI 2.0, currently under premarket approval review by the U.S. Food and Drug Administration, integrates AI. This advanced system is designed to assist surgeons in more efficiently detecting suspicious tissue during breast-conserving surgery.
Powering AI Development with Diverse, Real-World Data
A primary challenge in developing non-generative AI for medical applications lies in acquiring large, diverse datasets that accurately reflect a wide range of patient characteristics, including age, ethnicity, tissue density, and body mass. To develop its ImgAssist AI algorithm, Perimeter trained its deep learning models using several million proprietary OCT images of both cancerous and healthy tissue. These models, created by the company’s dedicated AI team, are designed for real-time application during surgery.
The launch of the OCT-Tissue Surveillance Registry empowers Perimeter to utilize real-world images and clinical data to further refine and sophisticate its AI model. Importantly, the registry also allows surgeons to contribute retrospective data and track patient outcomes, enabling the evaluation of surgical results over time.
